Alvogen And Zentiva Complete CEE Deal

Alvogen Aims To Focus On US And Asia-Pacific Regions

Alvogen’s central and eastern European business, which started up in 2010, has now been sold to the Zentiva group. Zentiva plans to combine both companies’ branded generics and OTC businesses in the CEE region.

Europe
Alvogen has sold its CEE business to Zentiva for an undisclosed sum • Source: Shutterstock

Alvogen has completed the sale of its central and eastern European business to Zentiva. The deal – first announced in October Also see "Zentiva Snaps Up Alvogen’s CEE Operations" - Generics Bulletin, 25 October, 2019. – has seen Alvogen sell over 200 generic and over-the-counter products across multiple therapeutic areas consisting of brands such as Lactacyd, Persen, EuBiotic and covering 14 key markets, for an undisclosed value.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business